When the heart skips a beat: research from discovery science through to benefits for patients and the NHS. Throughout the ...

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early trial suggests. But questions remain.

In 1775, 250 years ago, William Withering, a physician practising in Birmingham, learnt of a folk remedy for dropsy involving the use of digitalis from purple foxgloves. He started to use it in his ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill ...

Switching from beta-blockers to digoxin as first line therapy for heart rate control in older patients with atrial fibrillation (AF) and symptoms of heart failure could produce a cost saving of over ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a considerable amount of money ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was ...

The team reported on the study results in Nature Medicine, in a paper titled, “Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial ...